Multiple Myeloma

A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Also Known As:

Plasma Cell Myeloma; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Multiple Myelomas; Myeloma, Multiple; Myeloma, Plasma Cell; Myelomas, Multiple; Myelomas, Plasma Cell; Myelomas, Plasma-Cell; Plasma Cell Myelomas; Plasma-Cell Myeloma; Plasma-Cell Myelomas; Myeloma, Plasma-Cell

Neoplasms: 421329
- Neoplasms by Histologic Type: 1
  - Plasma Cell Neoplasms: 41
    - Multiple Myeloma: 8888
Cardiovascular Diseases: 21011
- Vascular Diseases: 7590
  - Hemostatic Disorders: 105
    - Multiple Myeloma: 8888
Hemic and Lymphatic Diseases
- Hematologic Diseases: 1465
  - Hemorrhagic Disorders: 428
    - Hemostatic Disorders: 105
      - Multiple Myeloma: 8888
  - Blood Protein Disorders: 13
    - Paraproteinemias: 1721
      - Multiple Myeloma: 8888
Immune System Diseases: 1311
- Immunoproliferative Disorders: 24
  - Lymphoproliferative Disorders: 2350
    - Multiple Myeloma: 8888
  - Paraproteinemias: 1721
    - Multiple Myeloma: 8888

D M Tollefsen Selected Research

D M Tollefsen Research Topics

Disease

Drug/Important Bio-Agent (IBA)